Zhi Ji

1.4k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Zhi Ji is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Zhi Ji has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Zhi Ji's work include Gastric Cancer Management and Outcomes (12 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Zhi Ji is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Zhi Ji collaborates with scholars based in China, Ethiopia and United States. Zhi Ji's co-authors include Shaohua Ge, Yi Ba, Tao Ning, Yuchong Yang, Ting Deng, Haiyang Zhang, Guoguang Ying, Le Zhang, Dongying Liu and Haiou Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and FEBS Letters.

In The Last Decade

Zhi Ji

28 papers receiving 1.1k citations

Hit Papers

CAF secreted miR-522 suppresses ferroptosis and promotes ... 2020 2026 2022 2024 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
    2020 776 citations Haiyang Zhang, Ting Deng et al. Molecular Cancer profile →

Peers

Zhi Ji
Qiumo Zhang China
Yicong Wan China
Xinyin Liu China
Misha Mao China
Lixin Zheng China
Liqiao Fan China
Jinwu Peng China
Peihua Liu China
Alessandro Sacco Italy
Xiulan Zheng China
Qiumo Zhang China
Zhi Ji
Citations per year, relative to Zhi Ji Zhi Ji (= 1×) peers Qiumo Zhang

Countries citing papers authored by Zhi Ji

Since Specialization
Citations

This map shows the geographic impact of Zhi Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Ji more than expected).

Fields of papers citing papers by Zhi Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Ji. The network helps show where Zhi Ji may publish in the future.

Co-authorship network of co-authors of Zhi Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Ji. A scholar is included among the top collaborators of Zhi Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Ji. Zhi Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Rui, Zhi Ji, Xia Wang, et al.. (2025). Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial. Nature Communications. 16(1). 1481–1481. 5 indexed citations
2.
3.
4.
Duan, Jingjing, Yinghui Shi, Weixue Wang, et al.. (2024). Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study. BMC Cancer. 24(1). 302–302. 3 indexed citations
5.
Li, Hongli, Shaohua Ge, Fenglin Zang, et al.. (2024). Updated results of perioperative PD-1 antibody toripalimab plus FLOT chemotherapy for locally advanced resectable gastric or gastro-esophageal junction adenocarcinoma: A one-arm open-table phase II trial.. Journal of Clinical Oncology. 42(16_suppl). e16128–e16128. 1 indexed citations
6.
Ji, Zhi, Xia Wang, Hongli Li, et al.. (2024). Multiomics reveals tumor microenvironment remodeling in locally advanced gastric and gastroesophageal junction cancer following neoadjuvant immunotherapy and chemotherapy. Journal for ImmunoTherapy of Cancer. 12(12). e010041–e010041. 6 indexed citations
7.
8.
Ji, Zhi, Qihang Chen, Yuanyan Wei, et al.. (2023). Siglec15 promotes the migration of thyroid carcinoma cells by enhancing the EGFR protein stability. Glycobiology. 33(6). 464–475. 5 indexed citations
9.
Zhang, Ruixue, et al.. (2023). PEDF Prevents Mitochondrial Function Decay and ER Stress Induced by Rotenone in Aging RPE Cells. Frontiers in Bioscience-Landmark. 28(11). 319–319. 3 indexed citations
10.
Wei, Yuanyan, Qihang Chen, Yingchao Liu, et al.. (2022). The Interaction between DNMT1 and High‐Mannose CD133 Maintains the Slow‐Cycling State and Tumorigenic Potential of Glioma Stem Cell. Advanced Science. 9(26). e2202216–e2202216. 28 indexed citations
11.
Li, Jiaoyuan, Ke Liu, Zhi Ji, et al.. (2022). Serum untargeted metabolomics reveal metabolic alteration of non‐small cell lung cancer and refine disease detection. Cancer Science. 114(2). 680–689. 18 indexed citations
12.
Liang, Ziwei, Zhi Ji, Wei-Tao Liu, et al.. (2021). The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells. Cancer Letters. 513. 90–100. 14 indexed citations
13.
Li, Hongli, Jingyu Deng, Shaohua Ge, et al.. (2021). Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.. Journal of Clinical Oncology. 39(15_suppl). 4050–4050. 17 indexed citations
14.
15.
Zhang, Haiyang, Ting Deng, Rui Liu, et al.. (2020). CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Molecular Cancer. 19(1). 43–43. 776 indexed citations breakdown →
16.
Ji, Zhi, Ying Li, Xiang Cheng, et al.. (2020). TERT-rs33963617 and CLPTM1L-rs77518573 reduce the risk of non-small cell lung cancer in Chinese population. Gene. 731. 144357–144357. 2 indexed citations
17.
Ji, Zhi, Yong Cui, Zhi Peng, et al.. (2020). Use of Radiomics to Predict Response to Immunotherapy of Malignant Tumors of the Digestive System. Medical Science Monitor. 26. e924671–e924671. 10 indexed citations
18.
Ji, Zhi, Peihong Yuan, Tingting Long, et al.. (2020). Nut Consumption and Risk of Cancer: A Meta-analysis of Prospective Studies. Cancer Epidemiology Biomarkers & Prevention. 29(3). 565–573. 22 indexed citations
19.
Ji, Zhi, Zhi Peng, Jifang Gong, et al.. (2019). Hyperprogression after immunotherapy in patients with malignant tumors of digestive system. BMC Cancer. 19(1). 705–705. 29 indexed citations
20.
Yang, Yuxia, et al.. (2016). RBM15 Functions in Blood Diseases. Current Cancer Drug Targets. 16(7). 579–585. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiumo Zhang Breakdown of academic impact, for papers by Yicong Wan Breakdown of academic impact, for papers by Xinyin Liu Breakdown of academic impact, for papers by Misha Mao Breakdown of academic impact, for papers by Lixin Zheng Breakdown of academic impact, for papers by Liqiao Fan Breakdown of academic impact, for papers by Jinwu Peng Breakdown of academic impact, for papers by Peihua Liu Breakdown of academic impact, for papers by Alessandro Sacco Breakdown of academic impact, for papers by Xiulan Zheng
Rankless by CCL
2026